26 results about "Herba Scutellariae Barbatae" patented technology

The use of a Reyanning formulation in the preparation of a drug for preventing and treating prostatitis. The Reyanning formulation is prepared from dandelion, giant knotweed rhizome, sonchi arvensis herba and herba scutellariae barbatae. The present application finds that the Reyanning formulation can reduce the contents of IL-6, IL-1β, NO and MDA in the serum of model rats, HE staining results show that the Reyanning formulation has certain relieving effect on the damage of prostate tissue, and it can be concluded from the molecular and tissue levels that the Reyanning formulation has certain prevention and treatment effect on chronic non-bacterial prostatitis.

The invention relates to the technical field of cordyceps sinensis, and particularly discloses cordyceps sinensis sporocarp electuary as well as a preparation method and application thereof. The medicinal material formula of the cordyceps sinensis sporocarp electuary is prepared from the following raw materials by weight: 35 to 45 g of cordyceps sinensis sporocarp powder, 16 to 22 g of radix ophiopogonis, 15 to 20 g of radix asparagi, 10 to 15 g of radix glehniae, 10 to 15 g of radix adenophorae, 25 to 35 g of rhizoma polygonati, 26 to 32 g of radix astragali seu hedysari, 10 to 15 g of radix angelicae sinensis, 25 to 34 g of caulis spatholobi, 25 to 30 g of solanum lyratum, 15 to 25 g of herba scutellariae barbatae, 25 to 30 g of oldenlandia diffusa, 25 to 35 g of salvia chinensis, 25 to 30 g of raw malt, 25 to 30 g of rice sprout, 25 to 30 g of medicated leaven and 8 to 12 g of periostracum cicadae. The cordyceps sinensis sporocarp electuary can be used for treating lung cancer, and has the advantages of strengthening the body resistance, resisting cancer and decomposing tumors.

The invention provides a traditional Chinese medicine composition, a preparation method and application thereof and a pharmaceutical composition. The traditional Chinese medicine composition comprises radix pseudostellariae, astragalus membranaceus, sculellaria barbata, houttuynia cordata, radix bupleuri, semen coicis, rhizoma polygonati, platycodon grandiflorum and liquorice. The traditional Chinese medicine composition provided by the invention is high in safety, long in application period, outstanding in immune regulation function, low in drug resistance risk, remarkable in comprehensive curative effect, wide in adaptation disease range and flexible in clinical application, and multiple mechanisms are cooperated.

The invention discloses a traditional Chinese medicine composition for treating constipation as well as a preparation method and application thereof, and belongs to the technical field of traditional Chinese medicines. The composition comprises the following components in parts by weight: 45 to 85 parts of Chinese pulsatilla root, 45 to 85 parts of oldenlandia diffusa, 45 to 85 parts of sculellaria barbata, 80 to 140 parts of Chinese actinidia root, 45 to 85 parts of trogopterus dung, 80 to 140 parts of coix seed, 80 to 140 parts of poria cocos, 80 to 140 parts of rhizoma pinellinae praeparata, 45 to 85 parts of pericarpium citri reticulatae, 60 to 100 parts of bighead atractylodes rhizome, 45 to 85 parts of endothelium corneum gigeriae galli, 60 to 100 parts of white hyacinth bean, 60 to 100 parts of dried ginger and 45 to 85 parts of liquorice. The traditional Chinese medicine composition has a good treatment effect on constipation caused by gastrointestinal tumors, is mild in medicine property, and is specially developed for patients with constipation caused by tumors.

The invention discloses a herbal nose-soothing health-care liquid and a preparation method thereof, and particularly relates to the technical field of rhinitis medicine preparation, and the herbal nose-soothing health-care liquid comprises the following components in parts by weight: 5-15 parts of angelica sinensis, 5-15 parts of salvia miltiorrhiza, 5-15 parts of ligusticum wallichii, 5-15 parts of sculellaria barbata, 5-15 parts of sambucus williamsii, 5-15 parts of pseudo-ginseng, 3-10 parts of magnolia flower, 3-10 parts of centipeda minima, 10-20 parts of astragalus membranaceus and 1-3 parts of borneol. According to the preparation method, medicinal materials with different properties are subjected to grouping treatment, graded extraction of components with different polarities is achieved through gradient variable-pressure decoction, the yield of active components is increased and the flavor of the product is improved through ultrasonic-assisted enzymolysis and solid-state segmented fermentation, accurate enrichment of target components is achieved through a membrane separation and resin adsorption combined technology, and the purity of the product is improved. The stability of volatile components is remarkably improved through a cyclodextrin inclusion technology, and the preparation is ensured to be uniformly dispersed through a high-shear emulsification technology.

This invention belongs to the field of gastric disease treatment, specifically relating to a traditional Chinese medicine composition for treating chronic atrophic gastritis with intestinal metaplasia and its preparation method. The traditional Chinese medicine composition for treating chronic atrophic gastritis with intestinal metaplasia comprises the following raw materials in parts by weight: Agrimonia pilosa 10-15 parts, Cyperus rotundus 8-10 parts, Scutellaria barbata 10-15 parts, Lobelia chinensis 10-15 parts, Patrinia scabiosaefolia 13-17 parts, Scutellaria baicalensis 7-11 parts, Hedyotis diffusa 10-15 parts, Prunella vulgaris 10-15 parts, Hedyotis diffusa 5-7 parts, Perilla frutescens 8-10 parts, Coptis chinensis 5-7 parts, Angelica sinensis 5-7 parts, etc. This invention focuses on the core pathogenesis of damp-heat in the spleen and stomach and stagnation of gastric collaterals. The Chinese herbal composition has the effects of clearing heat and removing dampness, regulating qi and harmonizing the stomach, nourishing blood and unblocking collaterals. Clinically, it can significantly improve the OLGA / OLGIM stage of patients with chronic atrophic gastritis with intestinal metaplasia, with a total effective rate of 65.1%, providing a safe and effective Chinese medicine solution for precancerous lesions of the stomach.

This invention discloses a traditional Chinese medicine composition for treating liver fibrosis with damp-heat toxicity, comprising the following raw materials in parts by weight: 20-30 parts of processed turtle shell, 18-25 parts of Oldenlandia diffusa, 11-15 parts of Curcuma zedoaria, 20-30 parts of processed Salvia miltiorrhiza (wine-processed), 14-20 parts of Scutellaria barbata, 11-15 parts of Epimedium, 10-15 parts of Artemisia capillaris, 14-20 parts of Sedum sarmentosum, 7-10 parts of Bupleurum chinense, 7-10 parts of Curcuma longa, 6-8 parts of dried ginger, 11-15 parts of stir-fried Atractylodes macrocephala, 18-25 parts of Astragalus membranaceus, 7-10 parts of Prunus persica, 8-12 parts of Schisandra chinensis, 4-6 parts of Panax notoginseng (powder), 14-20 parts of Poria cocos, and 3-5 parts of Cinnamomum cassia. This traditional Chinese medicine composition is developed based on the principles of TCM syndrome differentiation and treatment for liver fibrosis with damp-heat toxicity, and has the expected therapeutic effect on this condition.

The application provides a traditional Chinese medicine preparation for treating diabetic nephropathy and a preparation method thereof, and belongs to the technical field of traditional Chinese medicine pharmacy. The traditional Chinese medicine preparation is prepared from traditional Chinese medicinal materials such as angelica, eucommia ulmoides, helicteres angustifolia, broussonetia papyrifera, radix paeoniae suffruticosae, curcuma longa, dendrobium, polygonatum, radix adnati, ligustrum lucidum, ipomoea purpurea, lagerstroemia indica, kochia scoparia, haes, pyrrosia lingua and herba barbatae, and has the effects of nourishing yin and kidney, promoting blood circulation to remove meridian obstruction and clearing heat and removing dampness. The traditional Chinese medicine preparation can up-regulate the expression levels of podocin and nephrin, inhibit inflammatory mediators, improve the blood sugar, urine protein, kidney function and kidney pathological injury of DN rats, provides a new idea for the treatment of diabetic nephropathy, and has a good development and application prospect.

This invention relates to a traditional Chinese medicine composition for treating primary liver cancer. The composition is made from the following raw materials in parts by weight: 25-30 parts of *Codonopsis pilosula*, 10-15 parts of *Cremastra appendiculata*, 15-20 parts of *Scutellaria barbata*, 20-25 parts of *Curcuma zedoaria*, 10-15 parts of *Polygonum cuspidatum*, and 5-10 parts of *Citrus reticulata*. This invention also provides applications of the traditional Chinese medicine composition. The "Liver-Clearing Formula" of this invention uses a combination of various traditional Chinese herbs, focusing on "damp-heat, phlegm, qi stagnation, and blood stasis." The six herbs are combined to both attack and tonify, supporting the body's resistance and eliminating pathogenic factors, aiming to achieve the goal of strengthening the body's resistance and reducing pathogenic factors, thus achieving the effects of clearing heat and dampness, promoting qi circulation, resolving phlegm, and breaking up blood stasis. This helps improve the patient's quality of life and prognosis. At the same time, the use of this traditional Chinese medicine is expected to reduce the toxicity and enhance the efficacy of Western medicine, reducing adverse reactions and achieving the best therapeutic effect.

This invention relates to the field of traditional Chinese medicine (TCM) technology, and particularly to a TCM composition for treating tinnitus. Its ingredients include: vinegar-processed turtle shell, stir-fried jujube seed, anemarrhena rhizome, phellodendron bark, rehmannia root, white peony root, poria cocos, fleeceflower root vine, scutellaria barbata, oldenlandia diffusa, stir-fried atractylodes macrocephala, prunella vulgaris, and cicada slough. The TCM composition of this invention exhibits significant multi-dimensional beneficial effects in treating tinnitus. Compared with Western medicine treatments, it avoids the side effects such as low blood pressure, dizziness, drowsiness, and dry mouth associated with vasodilators and antidepressants, and overcomes the drawbacks of physical therapy, which only temporarily relieves symptoms and cannot cure the condition. It has the advantages of holistic conditioning and fewer side effects, providing a safe, effective, and comprehensive treatment plan for tinnitus patients, and has high clinical application value and promotional significance.

The application discloses a traditional Chinese medicine composition for treating chronic atrophic gastritis with low-grade intra-epithelial neoplasia and a preparation method and application thereof. The traditional Chinese medicine composition is prepared from raw materials including radix astragali 10-15 parts, rhizoma atractylodis macrocephalae 8-10 parts, poria cocos 10-15 parts, pericarpium citri reticulatae 8-10 parts, rhizoma pinelliae 5-8 parts, cyperus rotundus 12-15 parts, panax notoginseng 3-5 parts, radix curcumae 10-12 parts, root of actinidia 15-20 parts, herba hedyotis diffusae 15-20 parts and herba scorpiuridis 10-15 parts. The traditional Chinese medicine composition has good effects of improving gastric mucosa atrophy and low-grade intra-epithelial neoplasia, and has important application prospects for development of drugs for simple chronic atrophic gastritis and chronic atrophic gastritis combined with low-grade intra-epithelial neoplasia.

The invention discloses a compound anti-cancer Chinese patent medicine based on multi-target synergism and a preparation method thereof, and relates to the technical field of traditional Chinese medicine compound anti-tumor, the compound is composed of panax notoginseng saponins, ornithogalum caudatum saponin, lance asiabell root polysaccharide, sculellaria barbata flavone, oldenlandia diffusa polysaccharide, zedoary turmeric oil and ganoderma triterpenes according to a specific proportion. Wherein the monarch drug accounts for 30%-40% of cooked panax notoginseng saponins, the ministerial drug accounts for 20%-35% of ornithogalum caudatum saponin, the ministerial drug accounts for 5%-10% of the radix astragali extract, the adjuvant drugs account for 10%-15% of the adjuvant drugs and the conductant drugs account for 5%-10% of the conductant drugs, the nano-liposome co-loading technology is adopted, fat-soluble components are loaded on a liposome hydrophobic layer, water-soluble components are loaded on a hydrophilic layer, the preparation effect that the encapsulation efficiency is larger than or equal to 95%, and the particle size is 80 + / -5 nm is achieved, and the preparation effect is good. Trehalose is added as a freeze-drying protective agent, so that the stability reaches 36 months, and the freeze-dried powder can be used for solid tumor treatment and postoperative recurrence prevention, is especially suitable for chemotherapy of drug-resistant tumors, and widens the application range of anti-tumor traditional Chinese medicines.

The present application relates to the field of traditional Chinese medicine, and is a traditional Chinese medicine composition for eliminating tumors and a preparation method thereof. Nowadays, the incidence of tumors is becoming younger and younger, and the current treatment mainly uses western medicines, which have large side effects and can cause other adverse reactions if taken for a long time. The present application is composed of the following drugs: Herba Lophatheri 30g, Radix Sophorae Tonkinensis 6g, Prunella vulgaris 15g, Berberis dictyophylla 15g, Fructus Lycii 12g, Herba Epimedium 30g, Radix Ginseng 9g, Radix Astragali 30g, Spatholobi Caulis 15g, Ganoderma lucidum 12g, Rhizoma Polygonati 30g, Rhizoma Corydalis 10g, Taxus chinensis var. mairei 9g. Compared with western medicine preparations, the present application has fast curative effect and small side effects. It has certain protective effect on WBC reduction caused by chemotherapy drugs. When used with chemotherapy drugs, the present application can significantly increase the effect of chemotherapy (P<0.01), so the dosage of chemotherapy drugs can be correspondingly reduced.

The invention relates to the technical field of nano material preparation, and particularly discloses a preparation method of nano micro-powder based on traditional Chinese medicine and sea salt composite smelting purification, the method comprises the following steps: according to the principle of monarch, minister, assistant and guide in traditional Chinese medicine, combining astragalus membranaceus, lucid ganoderma, sculellaria barbata, oldenlandia diffusa, salvia miltiorrhiza, ligusticum wallichii and deep sea salt; adopting supercritical COextraction combined with vacuum freeze drying to obtain traditional Chinese medicine extract powder; a high-purity sea salt mineral concentrate is obtained through electrolytic purification and molecular distillation; the two components are mixed according to a ratio of 3: 1 to 5: 1, the mixture is subjected to high-energy ball milling and jet milling to prepare composite micro-powder with a particle size of 50-200 nanometers, and a quality control system covering characters, identification, content determination and stability is established. According to the technical scheme, efficient compounding of traditional Chinese medicine effective components and sea salt mineral substances is achieved, the bioavailability, the treatment effect and the product stability of the medicine are remarkably improved, and a safe and efficient nano traditional Chinese medicine novel dosage form is provided for treatment of tumors and chronic diseases.

The invention discloses health-care tea for prostate and a preparation method thereof. The health-care tea for prostate comprises the following raw material components in parts by weight: 10-20 parts of sculellaria barbata, 10-20 parts of herba violae, 15-25 parts of purslane, 10-20 parts of radix paeoniae rubra, 150-250 parts of poria cocos, 150-250 parts of coix seeds and 8-12 parts of triquetrous tadehagi herb. The peony flower and bud tea is prepared from 80-120 parts of dried peony flower and bud, 100-200 parts of haw slices, 20-40 parts of snow pear freeze-dried powder, 10-20 parts of camellia pollen and 50-100 parts of green tea or oolong tea. Through scientific compatibility, medicinal materials capable of clearing heat and promoting diuresis, promoting blood circulation to remove blood stasis and tonifying spleen and kidney are combined with characteristic plant raw materials, through an optimized preparation process, prostate health is conditioned in a multi-target mode, and meanwhile the prostate health conditioning tea has excellent taste and stability.

This invention relates to the field of traditional Chinese medicine composition technology, and in particular to a traditional Chinese medicine composition for treating lung cancer and its preparation method, comprising composition one, composition two, and composition three; composition one, by weight parts, comprises: Astragalus membranaceus 20-45 parts, Polygonatum odoratum 15-30 parts, Ophiopogon japonicus 8-18 parts, Coix lacryma-jobi 20-45 parts, Phragmites communis 20-45 parts, and Glycyrrhiza uralensis 3-6 parts; composition two, by weight parts, comprises: Clematis armandii 9-15 parts, Actinidia chinensis root 15-30 parts, Scutellaria barbata 10-22 parts, Pinellia ternata 6-13 parts, Fritillaria thunbergii 6-13 parts, and Citrus reticulata peel 6-13 parts; composition three, by weight parts, comprises: Buthus martensii 3-8 parts. The traditional Chinese medicine composition prepared by this invention has the effects of invigorating qi and nourishing yin, clearing heat and detoxifying, resolving phlegm and dissipating nodules, and promoting blood circulation and unblocking collaterals. It overcomes the technical problems of existing anti-lung cancer chemotherapy drugs having large toxic side effects and easily developing drug resistance, as well as the limited anti-lung cancer effects of existing single or simple compound traditional Chinese medicines, and the lack of optimization in compatibility and process.

The invention relates to the technical field of traditional Chinese medicine preparations, in particular to a preparation method and application of a bone marrow focus targeting traditional Chinese medicine sustained release preparation. The traditional Chinese medicine sustained release preparation for targeting the bone marrow focus comprises the following raw materials in parts by mass: 15-25 parts of oldenlandia diffusa, 5-15 parts of sculellaria barbata, 20-30 parts of astragalus membranaceus, 10-20 parts of dandelion, 5-12 parts of herba violae, 5-15 parts of gynura bicolor, 1-3 parts of sodium alginate, 1-3 parts of hyperbranched polylysine, 1-2 parts of poloxamer, 1-5 parts of a polylactic acid-glycolic acid copolymer and 5-15 parts of a calcium chloride solution. And 5-10 parts of polyvinyl alcohol. The sustained and controllable release of the traditional Chinese medicine components in the osteomyelitis focus part is realized, the long-acting anti-infection and bone repair promoting potential is achieved, and the preparation method is simple and suitable for large-scale popularization and application.

The medicine is a traditional Chinese medicine preparation prepared by decocting and processing various traditional Chinese medicines according to their content proportions, mainly in the formula, content and application technology of the traditional Chinese medicine powder. The application mainly aims at rectal cancer, and by using the medicine formula, the above-mentioned symptoms can be effectively relieved and treated. The main protection content of the application is the medicine formula and dosage: asarum 3g, radix cyathulae 2g, radix paeoniae 3g, rubus 3g, herba taraxaci 14g, myrrh 5g, herba acronychodis 15g, herba epimedii 10g, herba decursii 5g, and herba pholiota 5g.

The invention discloses a traditional Chinese medicine composition for treating primary liver cancer as well as a preparation method and application thereof, and relates to the technical field of traditional Chinese medicines. The traditional Chinese medicine composition comprises the following components in parts by weight: 8-12 parts of radix bupleuri, 8-12 parts of radix paeoniae alba, 22-28 parts of codonopsis pilosula, 10-14 parts of poria cocos, 10-14 parts of bighead atractylodes rhizome, 10-14 parts of eclipta alba, 10-14 parts of glossy privet fruit, 8-12 parts of scutellaria baicalensis, 22-28 parts of sculellaria barbata, 22-28 parts of glabrous sarcandra herb, 6-12 parts of fiveleaf akebia fruit and 6-12 parts of curcuma zedoary. The traditional Chinese medicine composition provided by the invention is relatively good in curative effect and small in toxic and side effects. The traditional Chinese medicine composition has the multiple treatment effects of soothing liver and regulating qi, clearing damp and strengthening spleen, and dispersing blood stasis and removing stasis, can effectively inhibit proliferation, invasion and metastasis of liver cancer cells, regulates the immune microenvironment of liver cancer tumors, and plays a role in delaying and even reversing the progress of hepatitis B-liver cirrhosis-liver cancer.

Use of a traditional Chinese medicine in preparing a drug for preventing and treating nephritis. The traditional Chinese medicine is prepared from Taraxacum officinale, Polygonum cuspidatum, Sonchus oleroceus L., and Herba Scutellariae barbatae. Danio rerio is adopted for modeling. Animal experiments prove that the traditional Chinese medicine can be used for treating nephritis caused by aristolochic acid, protecting kidney functions and / or ameliorating renal dysfunction edema, and specifically, promoting glomerular filtration. 

The invention discloses a traditional Chinese medicine composition for improving immunity and a preparation method and application thereof, and belongs to the technical field of traditional Chinese medicine. The core of the composition is that the composition is prepared from the following raw material medicines in parts by weight: 25-35 parts of radix paeoniae alba, 25-35 parts of duchesnea indica, 20-30 parts of rhizoma anemarrhenae, 25-35 parts of sculellaria barbata and 25-35 parts of oldenlandia diffusa, preferably 28-32 parts of radix paeoniae alba, 28-32 parts of duchesnea indica, 23-27 parts of rhizoma anemarrhenae, 28-32 parts of sculellaria barbata and 28-32 parts of oldenlandia diffusa. The invention further provides a preparation method of the composition, and stable drug effect is ensured by accurately controlling parameters such as water adding, soaking time and slow fire decocting time. In addition, ginseng powder and dragon's blood powder can also be added to form a synergistic drug set. The traditional Chinese medicine composition is simple in formula and clear in monarch, minister, assistant and guide, has the effects of clearing away heat and toxic materials and regulating qi and blood, can effectively improve the human immune environment and enhance the immunity, is reliable in preparation process and is suitable for industrial production.

The invention provides a traditional Chinese medicine preparation for treating diabetic nephropathy and a preparation method thereof, and belongs to the technical field of traditional Chinese medicine preparation. The traditional Chinese medicine preparation is prepared from the following traditional Chinese medicine materials: angelica sinensis, eucommia ulmoides, flatstem milkvetch seed, fructus broussonetiae, mantis egg-case, turmeric, dendrobe, radix polygonati officinalis, radix glehniae, glossy privet fruit, campsis grandiflora, crape myrtle flower, fructus kochiae, lygodium japonicum, pyrrosia lingua, sculellaria barbata and the like. The traditional Chinese medicine preparation has the effects of nourishing yin and tonifying kidney, promoting blood circulation to remove meridian obstruction, clearing heat and promoting diuresis. The traditional Chinese medicine preparation can achieve the effect of improving blood sugar, urine protein, renal functions and kidney pathological injuries of DN rats by up-regulating expression levels of podocin and nephrin and inhibiting inflammatory mediators, provides a new thought for treatment of diabetic nephropathy, and has good development and application prospects.

The invention provides a fermented traditional Chinese medicine formula for preventing African swine fever and a preparation process thereof. The fermented traditional Chinese medicine formula is prepared from the following materials in parts by weight: 8-15 parts of herba houttuyniae, 5-10 parts of radix scutellariae, 10-15 parts of liquorice root, 10-20 parts of herba violae, 11-15 parts of flos puerariae, 10-15 parts of honeysuckle flower, 8-10 parts of rhizoma coptidis, 10-15 parts of rhizoma zingiberis, 8-15 parts of evodia lepta, 10-15 parts of peperomia blanda, 6-9 parts of rhizoma atractylodis macrocephalae, 10-15 parts of oldenlandia diffusa and 8-10 parts of herba scutellariae barbatae. The preparation method comprises the following preparation steps: step 1, cleaning the raw materials with clear water, putting the cleaned raw materials into a fermentation tank, fermenting the traditional Chinese medicine raw materials to eliminate the internal toxicity of part of traditional Chinese medicines, combining the traditional Chinese medicine formula with daily feed for pigs and drinking water according to the pathogenesis of the swine fever to achieve the effects of sterilizing, killing insects, clearing away heat and toxic materials, and improving the immunity of the swine; from the aspect of preventing respiratory tract, intestinal tract, throat and stomach diseases, the hog cholera problem is solved by preventing the hog cholera in advance.

The application discloses a traditional Chinese medicine composition for dispelling phlegm and dampness, scattering pulmonary nodules and reducing abnormal lung tumor marker level, which is composed of the following medicinal materials: 30-50 parts by weight of Herba Eupatrorii, 10-30 parts by weight of Herba Hedyotis Diffusae, 6-12 parts by weight of wild chrysanthemum, 6-12 parts by weight of Herba Taraxaci, 20-50 parts by weight of Radix Rehmanniae, 10-30 parts by weight of Lagenaria siceraria, 3-6 parts by weight of Radix Notoginseng, 6-12 parts by weight of Bamboo Shrub, 10-15 parts by weight of Poria cocos, 6-10 parts by weight of Pericarpium Citri Reticulatae, 6-12 parts by weight of Fructus Aurantii, 6-12 parts by weight of Acorus gramineus, 6-10 parts by weight of Radix Curcumae, 6-10 parts by weight of Ganoderma lucidum, 6-12 parts by weight of Huperzia serrata, 6-12 parts by weight of Rhizoma Pinelliae, 15-30 parts by weight of Prunella vulgaris, 6-10 parts by weight of honey Kudou, 6-12 parts by weight of Bletilla striata, 6-10 parts by weight of Ramulus Cinnamomi, 1-2 pieces of Solenocera crassicornis, 10-15 parts by weight of vinegar Biejia, 6-9 parts by weight of fried Gongcao, 15-30 parts by weight of calcined sea sponges. The application further provides application of the traditional Chinese medicine composition in preparation of a medicine for treating pulmonary nodules caused by phlegm and dampness and / or abnormal increase of serum lung tumor markers.

The application discloses a traditional Chinese medicine composition, a traditional Chinese medicine preparation and a preparation method and application thereof. The traditional Chinese medicine composition comprises the following components in mass parts: 12-18 parts of Astragalus membranaceus; 12-18 parts of Polygonatum; 12-18 parts of Polygoni Multiflori Radix; 15-21 parts of Semen Perillae; 12-18 parts of Semen Raphani; 12-18 parts of Fritillariae Thunbergii Bulbus; 27-33 parts of Herba Dispori; 7-13 parts of Herba Scutellariae; and 3-9 parts of Radix Glycyrrhizae. The traditional Chinese medicine composition is an oral medicine, the medicine is convenient to prepare, and the medicine experiment on a liver cancer rat model shows that the medicine can effectively relieve the progress of liver cancer, especially can greatly reduce the side effects of the medicine on patients during treatment of liver cancer. The medicine is applied to treatment of liver cancer in clinic, and has remarkable curative effect.